Presentation is loading. Please wait.

Presentation is loading. Please wait.

Reduced clearance of rocuronium and sugammadex in patients with severe to end- stage renal failure: a pharmacokinetic study†  L.M. Staals, M.M.J. Snoeck,

Similar presentations


Presentation on theme: "Reduced clearance of rocuronium and sugammadex in patients with severe to end- stage renal failure: a pharmacokinetic study†  L.M. Staals, M.M.J. Snoeck,"— Presentation transcript:

1 Reduced clearance of rocuronium and sugammadex in patients with severe to end- stage renal failure: a pharmacokinetic study†  L.M. Staals, M.M.J. Snoeck, J.J. Driessen, H.W. van Hamersvelt, E.A. Flockton, M.W. van den Heuvel, J.M. Hunter  British Journal of Anaesthesia  Volume 104, Issue 1, Pages (January 2010) DOI: /bja/aep340 Copyright © 2010 The Author(s) Terms and Conditions

2 Fig 1 Sugammadex plasma concentration vs time plots for patients with renal failure and control patients. (a) Median (range) sugammadex plasma concentration (µg ml–1) vs time (min), for time points up to 60 min after injection of sugammadex. (b) Semi-logarithmic plot: median (range) sugammadex plasma concentration (µg ml–1) vs time (h), for time points up to 48 h after injection of sugammadex. Plasma concentrations were below the limit of quantification after 8 h in the control group. The numbers (n) of samples at each time point are given for the renally impaired group. British Journal of Anaesthesia  , 31-39DOI: ( /bja/aep340) Copyright © 2010 The Author(s) Terms and Conditions

3 Fig 2 Rocuronium plasma concentration vs time plots for patients with renal failure and control patients. (a) Median (range) rocuronium plasma concentration (ng ml–1) vs time (min) after administration of rocuronium and sugammadex, for time points up to 60 min after injection of sugammadex. (b) Semi-logarithmic plot: median (range) rocuronium plasma concentration vs time, for time points up to 48 h after administration of sugammadex. Plasma concentrations were below the lower limit of quantification after 18 h in the control group. The numbers (n) of samples at each time point are given for the renally impaired group. British Journal of Anaesthesia  , 31-39DOI: ( /bja/aep340) Copyright © 2010 The Author(s) Terms and Conditions

4 Fig 3 Regression plots of total plasma clearance (CL) of sugammadex and rocuronium vs CLCR (creatinine clearance) in normal controls and patients with renal insufficiency not yet on dialysis. (a) Regression plot of sugammadex CL vs CLCR (r=0.72) and (b) rocuronium CL vs CLCR (r=0.60). British Journal of Anaesthesia  , 31-39DOI: ( /bja/aep340) Copyright © 2010 The Author(s) Terms and Conditions


Download ppt "Reduced clearance of rocuronium and sugammadex in patients with severe to end- stage renal failure: a pharmacokinetic study†  L.M. Staals, M.M.J. Snoeck,"

Similar presentations


Ads by Google